Noninvasive tools to assess liver disease

Current Opinion in Gastroenterology

Volumn 27, Issue 3, 2011, Pages 210-216

  Clark, Paul J ^a   Patel, Keyur ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

biomarkers; biopsy; elastography; fibrosis; imaging

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CK 18 PROTEIN; CREATINE KINASE; HYALURONIC ACID; LIVER PROTEIN; MATRIX METALLOPROTEINASE; PROTHROMBIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; BIOPSY; BLOOD EXAMINATION; BODY MASS; CHRONIC LIVER DISEASE; ELASTOGRAPHY; EXTRACELLULAR MATRIX; FATTY LIVER; FIBROGENESIS; HEPATITIS C; HUMAN; INTERMETHOD COMPARISON; LIVER DISEASE; LIVER FIBROSIS; MEDICAL ASSESSMENT; NON INVASIVE PROCEDURE; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PROTHROMBIN TIME; RECEIVER OPERATING CHARACTERISTIC; THROMBOCYTE; THROMBOCYTE COUNT;

ALGORITHMS; BIOLOGICAL MARKERS; CHRONIC DISEASE; ELASTICITY IMAGING TECHNIQUES; HUMANS; LIVER DISEASES; PROGNOSIS;

EID: 79955070166     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e328343e9a3     Document Type: Article

References (42)

1. Rockey DC, Caldwell SH, Goodman ZD, et al. Liver biopsy. Hepatology 2009; 49:1017-1044.
2. Manning DS, Afdhal NH. Diagnosis and quantitation of fibrosis. Gastroenterology 2008; 134:1670-1681. (Pubitemid 351615414)
3. Smith JO, Sterling RK. Systematic review: noninvasive methods of fibrosis analysis in chronic hepatitis C. Aliment Pharmacol Therapeut 2009; 30:557-576.
4. Martínez SM, Crespo G, Navasa M, Forns X. Noninvasive assessment of liver fibrosis. Hepatology 2010. [Epub ahead of print]
5. Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol 2010; 7:425-436.
6. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371:838-851. (Pubitemid 351323895)
7. Duffield JS, Forbes SJ, Constandinou CM, et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Investig 2005; 115:56-65. (Pubitemid 40385505)
8. Calvaruso V, Burroughs AK, Standish R, et al. Computer-assisted image analysis of liver collagen: relationship to Ishak scoring and hepatic venous pressure gradient. Hepatology 2009; 49:1236-1244.
9. Gailhouste L, Grand YL, Odin C, et al. Fibrillar collagen scoring by second harmonic microscopy: a new tool in the assessment of liver fibrosis. J Hepatol 2010; 52:398-406.
10. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38:518-526. (Pubitemid 36919874)
11. Shaheen AAM, Myers RP. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review. Hepatology 2007; 46:912-921. (Pubitemid 47436137)
12. Sebastiani G, Halfon P, Castera L, et al. SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C. Hepatology 2009; 49:1821-1827.
13. Friedrich-Rust M, Ong M-F, Martens S, et al. Performance of Transient Elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008; 134:960.e8-974.e8.
14. Friedrich-Rust M, Wunder K, Kriener S, et al. Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus Transient Elastography. Radiology 2009; 252:595-604.
15. Talwalkar JA, Yin M, Fidler JL, et al. Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications. Hepatology 2008; 47:332-342. (Pubitemid 351171070)
16. Huwart L, Peeters F, Sinkus R, et al. Liver fibrosis: noninvasive assessment with MR elastography. NMR Biomed 2006; 19:173-179.
17. Huwart L, Sempoux C, Vicaut E, et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 2008; 135:32-40. (Pubitemid 351899024)
18. Casté ra L, Sebastiani G, Le Bail B, et al. Prospective comparison of two algorithms combining noninvasive methods for staging liver fibrosis in chronic hepatitis C. J Hepatol 2010; 52:191-198.
19. Mehta SH, Lau B, Afdhal NH, Thomas DL. Exceeding the limits of liver histology markers. J Hepatol 2009; 50:36-41.
20. Friedrich-Rust M, Rosenberg W, Parkes J, et al. Comparison of ELF, FibroTest and FibroScan for the noninvasive assessment of liver fibrosis. BMC Gastroenterol 2010; 10:103.
21. Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of nonalcoholic fatty liver disease (NAFLD) and diagnostic accuracy of noninvasive tests for liver disease severity. Ann Med 2010. [Epub ahead of print]
22. Wieckowska A, McCullough AJ, Feldstein AE. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology 2007; 46:582-589. (Pubitemid 47344794)
23. Feldstein AE, Wieckowska A, Lopez AR, et al. Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology 2009; 50:1072-1078.
24. Neuschwander-Tetri BA, Clark JM, Bass NM, et al. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology 2010; 52:913-924.
25. Calè s P, Lainé F, Boursier J, et al. Comparison of blood tests for liver fibrosis specific or not to NAFLD. J Hepatol 2009; 50:165-173.
26. Harrison SA, Oliver D, Arnold HL, et al. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut 2008; 57:1441-1447.
27. Wong VW-S, Vergniol J, Wong GL-H, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 2010; 51:454-462.
28. Kotronen A, Peltonen M, Hakkarainen A, et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology 2009; 137:865-872.
29. Poynard TM, Ngo M, Castera Y, et al. ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measure. Gastroenterol Clin Biol 2010; 34:388-396.
30. Casté ra L, Foucher J, Bernard P-H, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 2010; 51:828-835.
31. De Lé dinghen V, Vergniol J, Foucher J, et al. Feasibility of liver transient elastography with FibroScan1using a new probe for obese patients. Liver Int 2010; 30:1043-1048.
32. Shaheen AA, Myers R. Systematic review and meta-analysis of the diagnostic accuracy of fibrosis marker panels in patients with HIV/hepatitis C coinfection. HIV Clin Trials 2008; 9:43-51. (Pubitemid 351214240)
33. Nunes D, Fleming C, Offner G, et al. Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection. Am J Gastroenterol 2010; 105:1346-1353.
34. Sterling RK, Lyons CD, Stravitz RT, et al. Percutaneous liver biopsy in adult haemophiliacs with hepatitis C virus: safety of outpatient procedure and impact of human immunodeficiency virus coinfection on the spectrum of liver disease. Haemophilia 2007; 13:164-171. (Pubitemid 46237948)
35. Vidovic N, Lochowsky RS, Goldmann G, et al. Correlation of transient elastography with APRI and FIB-4 in a cohort of patients with congenital bleeding disorders and HCV or HIV/HCV coinfection. Haemophilia 2010; 16:778-785.
36. Naveau S, Gaude G, Asnacios A, et al. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Hepatology 2009; 49:97-105.
37. Nahon P, Kettaneh A, Tengher-Barna I, et al. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease. J Hepatol 2008; 49:1062-1068.
38. Mayo MJ, Parkes J, Adams-Huet B, et al. Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay. Hepatology 2008; 48:1549-1557.
39. Friedrich-Rust M, Müller C, Winckler A, et al. Assessment of liver fibrosis and steatosis in PBC with FibroScan, MRI,MR-spectroscopy, and serum markers. J Clin Gastroenterol 2010; 44:58-65.
40. Parkes J, Roderick P, Harris S, et al. Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease. Gut 2010; 59:1245-1251.
41. Ghany MG, Lok AS, Everhart JE, et al. Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C. Gastroenterology 2010; 138:136-146.
42. Fontana RJ, Dienstag JL, Bonkovsky HL, et al. Serum fibrosis markers are associated with liver disease progression in nonresponder patients with chronic hepatitis C. Gut 2010; 59:1401-1409.